‘Succession Syndrome’; Opioid Use Disorder LAI Approved; Seizures of Ketamine Rising

In what is being dubbed “Succession syndrome,” psychiatrists are warning against the harmful mental health effects of growing up in a powerful, wealthy family. (The Guardian)

There’s a new review to help primary care clinicians diagnose and manage depression in teens. “Primary care physicians and pediatricians are well positioned to support the assessment and first-line management of depression in this group, helping patients to regain their health and function,” the authors wrote in CMAJ.

In an effort to tackle mental illness, Colorado will now limit the use of body mass index when determining treatment for eating disorders and limit youth access to diet pills. (AP)

The 11-item Substance Use Symptom Checklist was helpful for primary care providers to pinpoint patients with substance use disorder. (JAMA Network Open)

The FDA approved the long-acting buprenorphine injectable (Brixadi), with weekly and monthly dosing, for moderate-to-severe opioid use disorder, maker Braeburn announced.

Ketamine’s increasing popularity as a mental health treatment has been accompanied by a rise in the number of seizures of illegal ketamine by federal, state, and local law enforcement agencies. (JAMA Psychiatry)

In other ketamine news, patients with refractory chronic migraine reported reduced headache intensity with ketamine nasal spray, a retrospective study showed. (Regional Anesthesia & Pain Medicine)

In a review of overnight sleep studies in patients with bipolar affective disorder and recurrent depressive disorder, researchers found significant links between obstructive sleep apnea and insomnia and the two psychiatric conditions. (Scientific Reports)